Human placenta under DMF controls from July.

Published: 2006-03-10 07:00:00

Updated: 2006-03-10 07:00:00

The crude human placenta for the use of drugs was classified as a bulk drug subjected to the DMF controls starting from July 1, which therefore causes for any human placenta drugs to fall under the KFDA's examination in its manufacture and quality according to the revised "guideline of bulk drug ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK